161 related articles for article (PubMed ID: 37943319)
1. Intrinsic and Dynamic Heterogeneity of Nonlamellar Lyotropic Liquid Crystalline Nanodispersions.
Yaghmur A; Moghimi SM
ACS Nano; 2023 Nov; 17(22):22183-22195. PubMed ID: 37943319
[TBL] [Abstract][Full Text] [Related]
2. Cubosomes and hexosomes as versatile platforms for drug delivery.
Azmi ID; Moghimi SM; Yaghmur A
Ther Deliv; 2015; 6(12):1347-64. PubMed ID: 26652281
[TBL] [Abstract][Full Text] [Related]
3. Temperature triggering of kinetically trapped self-assemblies in citrem-phospholipid nanoparticles.
Prajapati R; Salentinig S; Yaghmur A
Chem Phys Lipids; 2018 Nov; 216():30-38. PubMed ID: 30222973
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin Encapsulation Generates Morphologically Different Multicompartments in the Internal Nanostructures of Nonlamellar Liquid-Crystalline Self-Assemblies.
Azmi IDM; Østergaard J; Stürup S; Gammelgaard B; Urtti A; Moghimi SM; Yaghmur A
Langmuir; 2018 Jun; 34(22):6570-6581. PubMed ID: 29768016
[TBL] [Abstract][Full Text] [Related]
5. Cell medium-dependent dynamic modulation of size and structural transformations of binary phospholipid/ω-3 fatty acid liquid crystalline nano-self-assemblies: Implications in interpretation of cell uptake studies.
Bor G; Salentinig S; Şahin E; Nur Ödevci B; Roursgaard M; Liccardo L; Hamerlik P; Moghimi SM; Yaghmur A
J Colloid Interface Sci; 2022 Jan; 606(Pt 1):464-479. PubMed ID: 34399363
[TBL] [Abstract][Full Text] [Related]
6. Non-Lamellar Liquid Crystalline Nanocarriers for Thymoquinone Encapsulation.
Yaghmur A; Tran BV; Moghimi SM
Molecules; 2019 Dec; 25(1):. PubMed ID: 31861549
[TBL] [Abstract][Full Text] [Related]
7. Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.
Zhai J; Fong C; Tran N; Drummond CJ
ACS Nano; 2019 Jun; 13(6):6178-6206. PubMed ID: 31082192
[TBL] [Abstract][Full Text] [Related]
8. Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriers.
Wibroe PP; Mat Azmi ID; Nilsson C; Yaghmur A; Moghimi SM
Nanomedicine; 2015 Nov; 11(8):1909-14. PubMed ID: 26348655
[TBL] [Abstract][Full Text] [Related]
9. Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems.
Madheswaran T; Kandasamy M; Bose RJ; Karuppagounder V
Drug Discov Today; 2019 Jul; 24(7):1405-1412. PubMed ID: 31102731
[TBL] [Abstract][Full Text] [Related]
10. A structurally diverse library of glycerol monooleate/oleic acid non-lamellar liquid crystalline nanodispersions stabilized with nonionic methoxypoly(ethylene glycol) (mPEG)-lipids showing variable complement activation properties.
Yu Helvig S; Woythe L; Pham S; Bor G; Andersen H; Moein Moghimi S; Yaghmur A
J Colloid Interface Sci; 2021 Jan; 582(Pt B):906-917. PubMed ID: 32919118
[TBL] [Abstract][Full Text] [Related]
11. Advances in lyotropic liquid crystal systems for skin drug delivery.
Silvestrini AVP; Caron AL; Viegas J; Praça FG; Bentley MVLB
Expert Opin Drug Deliv; 2020 Dec; 17(12):1781-1805. PubMed ID: 32886531
[TBL] [Abstract][Full Text] [Related]
12. Oil transfer converts phosphatidylcholine vesicles into nonlamellar lyotropic liquid crystalline particles.
Martiel I; Handschin S; Fong WK; Sagalowicz L; Mezzenga R
Langmuir; 2015; 31(1):96-104. PubMed ID: 25485462
[TBL] [Abstract][Full Text] [Related]
13. Bioimaging Applications of Non-Lamellar Liquid Crystalline Nanoparticles.
Murgia S; Biffi S; Fornasier M; Lippolis V; Picci G; Caltagirone C
J Nanosci Nanotechnol; 2021 May; 21(5):2742-2759. PubMed ID: 33653441
[TBL] [Abstract][Full Text] [Related]
14. Coupling in vitro cell culture with synchrotron SAXS to understand the bio-interaction of lipid-based liquid crystalline nanoparticles with vascular endothelial cells.
Lam YY; Hawley A; Tan A; Boyd BJ
Drug Deliv Transl Res; 2020 Jun; 10(3):610-620. PubMed ID: 31997254
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effect of human plasma on the internal nanostructure and size characteristics of liquid-crystalline nanocarriers.
Azmi ID; Wu L; Wibroe PP; Nilsson C; Østergaard J; Stürup S; Gammelgaard B; Urtti A; Moghimi SM; Yaghmur A
Langmuir; 2015 May; 31(18):5042-9. PubMed ID: 25884233
[TBL] [Abstract][Full Text] [Related]
16. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
[TBL] [Abstract][Full Text] [Related]
17. A structurally diverse library of safe-by-design citrem-phospholipid lamellar and non-lamellar liquid crystalline nano-assemblies.
Azmi ID; Wibroe PP; Wu LP; Kazem AI; Amenitsch H; Moghimi SM; Yaghmur A
J Control Release; 2016 Oct; 239():1-9. PubMed ID: 27524284
[TBL] [Abstract][Full Text] [Related]
18. Understanding the interfacial properties of nanostructured liquid crystalline materials for surface-specific delivery applications.
Dong YD; Larson I; Barnes TJ; Prestidge CA; Allen S; Chen X; Roberts CJ; Boyd BJ
Langmuir; 2012 Sep; 28(37):13485-95. PubMed ID: 22889049
[TBL] [Abstract][Full Text] [Related]
19. A microfluidic platform for the controlled synthesis of architecturally complex liquid crystalline nanoparticles.
Pilkington CP; Contini C; Barritt JD; Simpson PA; Seddon JM; Elani Y
Sci Rep; 2023 Aug; 13(1):12684. PubMed ID: 37542147
[TBL] [Abstract][Full Text] [Related]
20. Cell interactions with lipid nanoparticles possessing different internal nanostructures: Liposomes, bicontinuous cubosomes, hexosomes, and discontinuous micellar cubosomes.
Yap SL; Yu H; Li S; Drummond CJ; Conn CE; Tran N
J Colloid Interface Sci; 2024 Feb; 656():409-423. PubMed ID: 38000253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
